Andreas Fibig to Leave Bayer HealthCare
Andreas Fibig, president of Bayer HealthCare Pharmaceuticals, will leave the company to become CEO of International Flavors & Fragrances on Sept. 1, 2014. Bayer said it would nominate a successor shortly.
Andreas Fibig, president of Bayer HealthCare Pharmaceuticals, will leave the company to become CEO of International Flavors & Fragrances on Sept. 1, 2014. Bayer said it would nominate a successor shortly.

Ineos CEO Ineos calls on European politicians to save the chemical industry.

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.


Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.

Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.